RC
ASMB icon

RBF Capital’s Assembly Biosciences ASMB Stock Holding History

RBF Capital’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,228
Closed -$12.1K – 555
2023
Q4 		$12.1K Hold
1,228
– – ﹤0.01% 547
2023
Q3 		$13K Hold
1,228
– – ﹤0.01% 533
2023
Q2 		$15.9K Hold
1,228
– – ﹤0.01% 526
2023
Q1 		$11.8K Hold
1,228
– – ﹤0.01% 509
2022
Q4 		$19K Hold
1,228
– – ﹤0.01% 524
2022
Q3 		$24K Hold
1,228
– – ﹤0.01% 525
2022
Q2 		$31K Hold
1,228
– – ﹤0.01% 520
2022
Q1 		$30K Hold
1,228
– – ﹤0.01% 514
2021
Q4 		$34K Hold
1,228
– – ﹤0.01% 514
2021
Q3 		$51K Hold
1,228
– – ﹤0.01% 476
2021
Q2 		$57K Hold
1,228
– – ﹤0.01% 481
2021
Q1 		$68K Hold
1,228
– – ﹤0.01% 442
2020
Q4 		$89K Buy
+1,228
New +$144K 0.01% 381

Other funds holding ASMB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.41M AUM 48.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RBF Capital's ASMB Position: Q1 2024 in Review

RBF Capital sold out of Assembly Biosciences (ASMB) in Q1 2024, closing a stake of 1,228 shares — an estimated $12.1K sold.

RBF Capital first reported a position in ASMB in Q4 2020 and held it in 13 quarters. The position peaked at $89K in Q4 2020. 24 funds tracked by Wall St. Rank hold ASMB as of Q1 2024.

  • RBF Capital reported no remaining Assembly Biosciences position as of Q1 2024 after selling out during the quarter.
  • RBF Capital sold 1,228 Assembly Biosciences shares in Q1 2024, an estimated $12.1K.
  • RBF Capital first reported a position in Assembly Biosciences in Q4 2020 and held it in 13 quarters.
  • RBF Capital's Assembly Biosciences position peaked at $89K in Q4 2020.
  • 24 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2024.

Based on RBF Capital's 13F filing for Q1 2024, filed 15 May 2024.